Aptevo Therapeutics Inc.APVONASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank8
3Y CAGR-5.9%
5Y CAGR-3.6%
Year-over-Year Change
Research and development spending
3Y CAGR
-5.9%/yr
vs -15.7%/yr prior
5Y CAGR
-3.6%/yr
Consistent
Acceleration
+9.8pp
Accelerating
Percentile
P8
Near historical low
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $14.88M | +3.5% |
| 2024 | $14.38M | -16.0% |
| 2023 | $17.11M | -4.3% |
| 2022 | $17.88M | -5.9% |
| 2021 | $18.99M | +6.4% |
| 2020 | $17.85M | -27.9% |
| 2019 | $24.76M | -30.0% |
| 2018 | $35.38M | +21.9% |
| 2017 | $29.02M | -1.7% |
| 2016 | $29.52M | - |